Thyroid cancer and autoimmune connective tissue disorders.

Area of Science:

• Endocrinology
• Rheumatology
• Oncology

Background:

• Autoimmune disorders, specifically connective tissue diseases (CTDs), are associated with an increased risk of thyroid malignancy.
• CTDs and thyroid cancer can coexist due to high population incidence or arise from each other, particularly with conditions like rheumatoid arthritis and systemic lupus erythematosus.
• In rare instances, CTDs may present as paraneoplastic syndromes of thyroid cancer.

Purpose of the Study:

• To emphasize the critical aspects of the interrelationship between CTDs and thyroid cancer.
• To explain potential linking mechanisms between these conditions.
• To present the impact of CTDs on thyroid cancer management and cancer therapy's effects on skeletal health.

Main Methods:

• Literature review focusing on the association between autoimmune disorders and thyroid malignancy.
• Analysis of diagnostic challenges posed by CTDs in thyroid cancer.
• Examination of treatment implications, including TSH suppression and its effect on bone health.

Main Results:

• CTDs can distort diagnostic tests for thyroid cancer, leading to misinterpretation of imaging and biomarkers.
• Management of differentiated thyroid cancer, particularly TSH suppression, may negatively impact bone mineral density and increase osteoporosis risk.
• The interplay between CTDs and thyroid cancer influences diagnostic accuracy, treatment strategies, and patient skeletal health.

Conclusions:

• Understanding the link between CTDs and thyroid cancer is crucial for accurate diagnosis and effective management.
• The presence of CTDs requires careful consideration during thyroid cancer workup and treatment planning.
• Further research into the mechanisms and clinical implications of this association is warranted to optimize patient outcomes.